Tedeschi, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 1.542
AS - Asia 851
EU - Europa 583
SA - Sud America 151
Continente sconosciuto - Info sul continente non disponibili 41
AF - Africa 18
OC - Oceania 6
Totale 3.192
Nazione #
US - Stati Uniti d'America 1.481
SG - Singapore 408
IT - Italia 252
CN - Cina 192
BR - Brasile 118
SE - Svezia 92
VN - Vietnam 70
IN - India 53
FR - Francia 49
DE - Germania 46
IE - Irlanda 36
JP - Giappone 30
CA - Canada 28
GB - Regno Unito 23
FI - Finlandia 22
ID - Indonesia 22
AR - Argentina 14
MX - Messico 14
RU - Federazione Russa 12
BD - Bangladesh 11
HK - Hong Kong 11
IQ - Iraq 11
KR - Corea 10
ES - Italia 9
PL - Polonia 7
EC - Ecuador 6
IL - Israele 6
AT - Austria 5
NL - Olanda 5
UA - Ucraina 5
ZA - Sudafrica 5
AU - Australia 4
CR - Costa Rica 4
JM - Giamaica 4
AL - Albania 3
CO - Colombia 3
CW - ???statistics.table.value.countryCode.CW??? 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EE - Estonia 3
EG - Egitto 3
NO - Norvegia 3
PK - Pakistan 3
PR - Porto Rico 3
SA - Arabia Saudita 3
TR - Turchia 3
VE - Venezuela 3
BO - Bolivia 2
GT - Guatemala 2
GY - Guiana 2
JO - Giordania 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AW - Aruba 1
AZ - Azerbaigian 1
BE - Belgio 1
BS - Bahamas 1
CH - Svizzera 1
DK - Danimarca 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MD - Moldavia 1
NG - Nigeria 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.155
Città #
Singapore 256
Ashburn 166
San Jose 113
Florence 73
New York 55
Beijing 52
Chandler 50
Hyderabad 39
Dublin 33
Hefei 33
Council Bluffs 30
Tokyo 29
Rome 27
Dallas 26
Milan 26
Los Angeles 24
Atlanta 23
Lauterbourg 23
Ho Chi Minh City 20
Jakarta 20
Chicago 18
Hanoi 17
Frankfurt am Main 16
Tukwila 16
São Paulo 15
Memphis 12
Hong Kong 10
Kent 10
North Bergen 10
Seoul 10
Phoenix 9
Princeton 9
Santa Clara 9
Helsinki 8
Lappeenranta 8
Wilmington 8
London 7
Montreal 7
San Mateo 7
The Dalles 7
Washington 7
Boston 6
Denver 6
Munich 6
Nuremberg 6
San Francisco 6
St Louis 6
Toronto 6
Turku 6
Dearborn 5
Moscow 5
Naples 5
Orem 5
Paris 5
Acerra 4
Agrolândia 4
Baghdad 4
Benalla 4
Brooklyn 4
Da Nang 4
Düsseldorf 4
Elk Grove Village 4
Haiphong 4
Jacksonville 4
Pellezzano 4
Rio de Janeiro 4
Seattle 4
Turin 4
Vancouver 4
Amsterdam 3
Asti 3
Boardman 3
Brescia 3
Cairo 3
Johannesburg 3
Lindale 3
Manchester 3
Miami 3
Norwalk 3
Padua 3
Pune 3
Querétaro 3
Ramsey 3
San Antonio 3
Sesto Fiorentino 3
Verona 3
Willemstad 3
Agawam 2
Amman 2
Bagheria 2
Bari 2
Basra 2
Belo Horizonte 2
Berzo Inferiore 2
Biên Hòa 2
Bologna 2
Bremen 2
Bruino 2
Brusciano 2
Buffalo 2
Totale 1.551
Nome #
Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia 307
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia 254
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model 252
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 169
Prognostic impact and risk factors of infections in patients with chronic lymphocytic leukemia treated with ibrutinib 148
Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion 138
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 129
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial 127
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia 124
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study 124
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group 123
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study 119
Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes 114
I complessi sacri e i culti di Praeneste tra l'età arcaica e l'età tardo repubblicana 112
Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib? 108
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 106
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement 102
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia 97
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 92
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia 90
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort 85
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement 79
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study 70
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort 65
Takotsubo syndrome after BNT162b2 mRNA Covid-19 vaccine: Emotional or causative relationship with vaccination? 40
Predicting acceptance and adoption of renewable energy community solutions: the prosumer psychology 18
Totale 3.192
Categoria #
all - tutte 12.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.733


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202285 0 0 0 17 11 3 4 9 5 5 25 6
2022/2023194 30 23 14 11 11 22 3 12 24 8 32 4
2023/2024344 16 55 36 57 20 80 17 4 1 7 12 39
2024/2025444 8 4 37 8 52 22 10 16 31 73 115 68
2025/20261.199 170 27 71 159 221 74 185 73 72 75 52 20
2026/2027859 58 547 57 197 0 0 0 0 0 0 0 0
Totale 3.192